Pulmonx Corp
NASDAQ:LUNG

Watchlist Manager
Pulmonx Corp Logo
Pulmonx Corp
NASDAQ:LUNG
Watchlist
Price: 1.91 USD 2.69%
Market Cap: $78.8m

Relative Value

The Relative Value of one LUNG stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.91 USD, Pulmonx Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LUNG Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

LUNG Competitors Multiples
Pulmonx Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pulmonx Corp
NASDAQ:LUNG
78.8m USD 0.8 -1.4 -0.7 -0.7
JP
Hoya Corp
TSE:7741
8.7T JPY 9.7 41.4 25.7 30.7
CH
Alcon AG
SIX:ALC
31.5B CHF 3.9 38.4 20.1 39
US
Medline Inc
NASDAQ:MDLN
37.3B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
122.5B DKK 4.4 33.6 15.5 18.4
US
Align Technology Inc
NASDAQ:ALGN
12.2B USD 3.1 32.3 14.6 18.6
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.8 30 18 29.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44B CNY 9.7 26.8 24.1 24.1
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD 1.2 -19.7 19.6 92.4
CH
Ypsomed Holding AG
SIX:YPSN
4.6B CHF 5.8 23.7 15.3 20.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.9B USD 3.3 40.7 18.6 30.9
P/E Multiple
Earnings Growth PEG
US
Pulmonx Corp
NASDAQ:LUNG
Average P/E: 33.4
Negative Multiple: -1.4
N/A N/A
JP
Hoya Corp
TSE:7741
41.4
13%
3.2
CH
Alcon AG
SIX:ALC
38.4
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.6
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
32.3
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
30
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.8
10%
2.7
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
23.7
34%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
40.7
30%
1.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Pulmonx Corp
NASDAQ:LUNG
Average EV/EBITDA: 19.1
Negative Multiple: -0.7
N/A N/A
JP
Hoya Corp
TSE:7741
25.7
11%
2.3
CH
Alcon AG
SIX:ALC
20.1
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.5
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.6
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
18
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
15.3
21%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
18.6
16%
1.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Pulmonx Corp
NASDAQ:LUNG
Average EV/EBIT: 33.8
Negative Multiple: -0.7
N/A N/A
JP
Hoya Corp
TSE:7741
30.7
N/A N/A
CH
Alcon AG
SIX:ALC
39
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.4
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.3
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
11%
2.2
CA
Bausch + Lomb Corp
NYSE:BLCO
92.4
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
20.8
29%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
30.9
30%
1